Abstract OBJECTIVES: Red cell distribution width (RDW) has been identified as an independent risk factor with regard to prognosis in patients with cardiac disease. We sought to investigate the association of RDW in patients undergoing lung resections for non-small-cell lung cancer with respect to in-hospital morbidity, mortality and long-term survival.
INTRODUCTION
Red cell distribution width (RDW) is a measure of the variability in the volume of red blood cells, and is utilized to narrow the differential diagnosis of anaemia [1] . The term 'width' refers to the width of the volume curve, and not the width of the red cell. Mathematically, the RDW is calculated with the following formula: (standard deviation [SD] of MCV/mean MCV) × 100, where MCV represents mean corpuscular volume.
To date, RDW has been shown to be a significant factor determining long-term survival in patients with cardiac disease, but no publications exist in the area of oncology [2, 3] . RDW interpretation needs to be taken in conjunction with haemoglobin levels [4] . Cardiovascular events are responsible for a number of deaths after potentially curative resections for non-small-cell lung cancer [5] .
We sought to investigate the effect of RDW, after adjustment for haemoglobin level, on in-hospital morbidity, superficial thoracotomy wound infections, postoperative respiratory support, length of stay, in-hospital mortality and long-term survival.
METHODS
Local institutional review board permission was granted for this retrospective study. The characteristics of the study population are given in Table 1 . All RDW measurements were made preoperatively, within 30 days, in a single university-associated dedicated haematology laboratory. The study cohort was from 1 January 2003 to 31 December 2008. As previously described, the national strategic tracing service in the UK was utilized to track patients' long-term survival [6, 7] Fig. 1A . Univariate analysis was performed to assess the effects of RDW on postoperative length of stay, in-hospital mortality and long-term survival (Fig. 1D) . We used χ 2 or one-way analysis of variance, to test for differences in categorical or continuous factors between different quartiles of RDW.
An initial multivariate linear regression analysis was performed to identify the factors that are significantly associated with an elevated RDW, as previously described [2] . This allowed these factors to be incorporated in the following multivariate analysis.
In-hospital mortality was assessed by stepwise logistic regression analysis. Length of stay was assessed by linear regression analysis. Long-term survival was assessed by stepwise Cox regression analysis. Entry criterion was P < 0.05, and removal criterion was P > 0.1, for multivariate analysis. Cox regression analysis was plotted at the mean of the covariates with RDW expressed by quartile (Fig. 2) . The confounding effect of haemoglobin was adjusted for, as previously described [2] . Variables used in all the multivariate analyses included: age, alcohol (units/week), predicted postoperative FEV1, preoperative haemoglobin, diabetes, tumour diameter, body mass index (BMI), cardiac history, respiratory history (emphysema and chronic obstructive airway disease), smoking status (current, ex and non), histology type (adenocarcinoma and squamous carcinoma), tumour, node, metastasis (TNM) stage, resection margin and operative intervention (wedge, lobectomy or pneumonectomy).
Statistical software
All statistical analysis was performed with MedCalc for Windows, version 12.2.1 (MedCalc Software, Mariakerke, Belgium).
RESULTS

Study population
Characteristics of the population studied, n = 917, are given in Table 1 . Overall mortality was 1.9% for all cases. RDW ranged from 11.8 to 26.7% (median, 14.2%; interquartile range, 13.5-15.3%; mean, 14.6) and 540 (41%) had RDW levels outside the normal range of 11.8-14.6% with RDW < 11.8, n = 0 and >14.6 (n = 540 [41%]). A 100% follow-up was achieved. Figure 1 demonstrates that RDW has a significant effect on hospital length of stay (P < 0.001), in-hospital mortality rates (P < 0.001) postoperative invasive and non-invasive ventilation (P < 0.001), superficial wound infections (P = 0.06) and long-term survival (P < 0.0001). Smoking status (current, ex and never) was not associated with RDW (P = 0.2).
Univariate analysis
Multivariate analysis
Factors associated with a raised RDW. Multiple linear regression demonstrated that age (P = 0.001), preoperative haemoglobin (P < 0.0001), a cardiac history P = 0.03, squamous histology subtype (P = 0.003) and the need for a pneumonectomy (P = 0.004) were significant factors determining a raised RDW (analysis without histology type and procedure type resulted in the same factors being identified-data not shown). 
In-hospital mortality
Long-term survival analysis
Multivariate Cox regression analysis demonstrated that RDW 4th quartile, (hazard ratio [HR] 1.54, P < 0.0001), age, (HR 1.03, P < 0.0001), alcohol intake, (HR 1.01, CI 1.00-1.01, P = 0.003), (Table 3) . Stepwise analysis excluded RDW quartile 2 and 3, preoperative haemoglobin, diabetes, BMI, cardiac history, histology type adeno or squamous, bronchial resection margin, Framingham risk score, Thoracoscore, and a clinical diagnosis of COPD or emphysema as being significant factors. RDW quartiles plotted at the mean of the covariates are shown in Fig. 2 .
Hospital length of stay
Linear regression demonstrated that RDW (P < 0.0001), age (P = 0.02), preoperative haemoglobin (P = 0.02), wedge resection (P = 0.0001), predicted postoperative FEV1 (P = 0.01) and Thoracoscore (P = 0.03) were significant factors determining hospital length of stay (Table 4C) , (R 2 adjusted 0.06). Stepwise analysis excluded postoperative T and N stages, BMI, alcohol, diabetes, peripheral vascular diseased, cardiac history, clinical diagnosis of COPD or emphysema, pack years, smoking status, histology type adeno or squamous carcinoma, pneumonectomy and Framingham risk score as being significant factors.
Confounding factor analysis
All of the above analyses were repeated excluding all patients with haemoglobin <10 g/dl, <11 g/dl and <12 g/dl. RDW was still a significant determinant in all the analyses (data not shown).
Superficial thoracotomy wound infections
Multiple logistic regression (Table 2B ), demonstrated that the 4th quartile of RDW was significantly associated with superficial wound infections (P = 0.01, ROC = 0.7). Stepwise regression eliminated age, alcohol, diabetes, tumour diameter, BMI, cardiac history, tumour stage, bronchial resection margin, predicted postoperative FEV1 wedge or pneumonectomy resections, clinical diagnosis of COPD and emphysema, histology types-squamous and adeno and preoperative haemoglobin, as being significant factors. This complication developed in only 14 cases.
Postoperative respiratory support
Multiple logistic regression (ROC = 0.8, Table 2C ), demonstrated that the 4th quartile of RDW (P = 0.002), cardiac history (P = 0.002), a clinical diagnosis of COPD (P = 0.002), and preoperative haemoglobin (P = 0.02) were significant factors determining non-invasive and invasive ventilation postoperatively. Stepwise analysis excluded age, alcohol intake, diabetes, BMI, RDW quartiles I-III, emphysema, histology-adeno or squamous, tumour diameter, bronchial resection margin, TNM stage, predicted postoperative FEV1 and operation type-wedge, lobectomy, pneumonectomy.
DISCUSSION
RDW is a significant determinant of length of hospital stay, in-hospital morbidity, superficial thoracotomy wound infections, need for postoperative respiratory support, in-hospital mortality and long-term survival post-potentially curative resections for non-small-cell lung cancer. To date, no studies exist in the field of lung cancer with regard to RDW. RDW is a well known significant factor determining long-term survival in patients with heart failure, a history of coronary artery disease, or those who have undergone a percutaneous coronary intervention [2] [3] [4] .
To reduce the risk of confounding, we adjusted for a comprehensive list of characteristics known to influence the outcome measures. We also determined factors that were associated with higher levels of RDW preoperatively and adjusted for these factors, as has been described previously [2] . This increases the likelihood that a higher RDW is independently associated with adverse outcomes, but the mechanism underlying this association is unclear. Causes of a raised RDW include nutritional deficiency (vitamin B12 or folate), and recent blood transfusion [8] , however we feel that this is unlikely, as no patients had M1 or unresectable disease, and preoperative blood transfusion is very rare.
Thoracoscore is a risk model for operative mortality after thoracic surgery [9] , and the Framingham risk score is a model to predict cardiovascular mortality [5] . We included both of these scores to try and adjust to surgical or cardiovascular confounding factors in addition to anaemia. RDW was still a significant factor in all outcomes measures analysed.
As with previous work, our RDW data are skewed. We identified age, preoperative haemoglobin, cardiac history, squamous histology and the need for a pneumonectomy as significant determinants of a high RDW. Previous work has identified age, and sex as significant determinants of a high RDW [2] . We are unable to replicate the sex bias finding.
In-hospital mortality was significantly affected by RDW values. Three separate analyses were performed excluding patients with a haemoglobin <10, 11 and 12 g/dl, and all identified RDW as a significant factor (data not shown), implying that the RDW effect is independent of haemoglobin levels until patients become very anaemic. Logistic regression is an asymptotic method, and there should be at least 10 events for each variable included into a multivariate logistic regression. The model for in-hospital mortality was repeated with RDW and alcohol, predicted postoperative FEV1, preoperative haemoglobin or Framingham risk score as a second covariate. RDW was a significant factor again in all analyses (data not shown).
RDW was a significant factor determining long-term survival. The highest quartile of RDW was the only quartile associated with a poor long-term outcome.
Three separate analyses were performed excluding patients with haemoglobin <10, 11 and 12 g/dl, and all identified RDW as a significant factor (data not shown).
Death post-resection for non-small-cell lung cancer is frequently respiratory in nature [10] . Length of stay is also predominantly determined by respiratory issues. The fact that RDW is a significant determinant of both may hint at a possible mechanism of association. RDW may actually be a biomarker of bone marrow function. In the short term, subtle bone marrow dysfunction may be associated with an increased incidence of respiratory infections masquerading as 'atelectasis'. We speculate, but offer no evidence, that long-term subtle bone marrow dysfunction may be associated with an increased incidence of infections due to white cell dysfunction, and an increased incidence of cardiovascular events due to platelet aggregation caused by platelet dysfunction. The demonstration that superficial thoracotomy wound infections, postoperative invasive and non-invasive ventilation for atelectasis/ infection and length of stay are significantly associated with RDW may offer tentative evidence supporting the subtle white cell dysfunction hypothesized above. Re-thoracotomy for bleeding was not associated with RDW values; however, only 18 cases (1.8%) required a re-thoracotomy (data not shown).
Bone marrow involvement by micro-metastatic non-small-cell in patients undergoing resectional surgery is known to exist. However, the prognostic effect of marrow involvement is debated [11, 12] . Complex immune mechanisms are known to exist between tumour and bone marrow, with interactions occurring in both directions [13] .
RDW is a significant factor, after risk adjustment, determining postoperative invasive and non-invasive ventilation, superficial wound infections, length of hospital stay, in-hospital mortality and long-term survival in patients undergoing post-potentially curative resections for non-small-cell lung cancer. Strengths of our analysis include its relatively large size and the use of a single laboratory for all assays. Further work is needed to elucidate the exact mechanism of RDW impact on in-hospital morbidity, mortality and long-term survival. We speculate that subtle bone marrow dysfunction may be an issue.
Limitations
We are unable to differentiate atelectasis from infection from our database. This is a common clinical problem, and not just a database issue, and explains the large number of culture-negative patients with atelectasis who are treated with antibiotics, nebulisers and physiotherapy with or without respiratory support. We are unable to differentiate postoperative CPAP, BIPAP and reventilation in our database. The mode of death is unknown in our study. Lung diffusion capacity (DLCO) is a known risk factor for respiratory failure post-lung resection surgery. Unfortunately, we do not have a complete electronic dataset for this, making any interpretation potentially erroneous. The results of this study need to be replicated by other centres to confirm or refute our findings.
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